Are Patient Decision Aids Used in Clinical Practice after Rigorous Evaluation? A Survey of Trial Authors

Patient decision aids (PtDAs) are effective interventions to support patient involvement in health care decisions, but there is little use in practice. Our study aimed to determine subsequent PtDA use in clinical practice following published randomized controlled trials. A descriptive study using an...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Medical decision making Ročník 39; číslo 7; s. 805
Hlavní autori: Stacey, Dawn, Suwalska, Victoria, Boland, Laura, Lewis, Krystina B, Presseau, Justin, Thomson, Richard
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States 01.10.2019
Predmet:
ISSN:1552-681X, 1552-681X
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Patient decision aids (PtDAs) are effective interventions to support patient involvement in health care decisions, but there is little use in practice. Our study aimed to determine subsequent PtDA use in clinical practice following published randomized controlled trials. A descriptive study using an e-mail-embedded questionnaire survey targeting authors of 133 trials included in Cochrane Reviews of PtDAs (106 authors). We classified PtDA level of use as a) implementation, defined as integrating within care processes; b) dissemination to target users with planned strategies; and c) diffusion, defined as passive, unplanned spread. We conducted content analysis to identify barriers and enablers guided by the Ottawa Model of Research Use. Ninety-eight authors responded (92.5%) on 108 trialed PtDAs. Reported levels of use were implementation ( = 29; 28%), dissemination to target user(s) ( = 9; 9%), and diffusion ( = 7; 7%); 57 (55%) reported no uptake, and 1 had no response (1%). Barriers to use in clinical practice were identified at the level of researchers (e.g., lack of posttrial plan), PtDAs (e.g., outdated, delivery mechanism), clinicians (e.g., disagreed with PtDA use), and practice environment (e.g., infrastructure support; funding). Enablers were online delivery, organizational endorsement (e.g., professional organization, charity, government), and design for and integration into the care process. Self-report bias and potential for recall bias. Only 44% of PtDA trial authors indicated some level of subsequent use following their trial. The most commonly reported barriers were lack of funding, outdated PtDAs, and clinician disagreement with PtDA use. To improve subsequent use, researchers should codesign PtDAs with end users to ensure fit with clinical practice and develop an implementation plan. National systems (e.g., platforms, endorsement, funding) can enable use.
AbstractList Background. Patient decision aids (PtDAs) are effective interventions to support patient involvement in health care decisions, but there is little use in practice. Our study aimed to determine subsequent PtDA use in clinical practice following published randomized controlled trials. Design. A descriptive study using an e-mail-embedded questionnaire survey targeting authors of 133 trials included in Cochrane Reviews of PtDAs (106 authors). We classified PtDA level of use as a) implementation, defined as integrating within care processes; b) dissemination to target users with planned strategies; and c) diffusion, defined as passive, unplanned spread. We conducted content analysis to identify barriers and enablers guided by the Ottawa Model of Research Use. Results. Ninety-eight authors responded (92.5%) on 108 trialed PtDAs. Reported levels of use were implementation (n = 29; 28%), dissemination to target user(s) (n = 9; 9%), and diffusion (n = 7; 7%); 57 (55%) reported no uptake, and 1 had no response (1%). Barriers to use in clinical practice were identified at the level of researchers (e.g., lack of posttrial plan), PtDAs (e.g., outdated, delivery mechanism), clinicians (e.g., disagreed with PtDA use), and practice environment (e.g., infrastructure support; funding). Enablers were online delivery, organizational endorsement (e.g., professional organization, charity, government), and design for and integration into the care process. Limitations. Self-report bias and potential for recall bias. Conclusions. Only 44% of PtDA trial authors indicated some level of subsequent use following their trial. The most commonly reported barriers were lack of funding, outdated PtDAs, and clinician disagreement with PtDA use. To improve subsequent use, researchers should codesign PtDAs with end users to ensure fit with clinical practice and develop an implementation plan. National systems (e.g., platforms, endorsement, funding) can enable use.Background. Patient decision aids (PtDAs) are effective interventions to support patient involvement in health care decisions, but there is little use in practice. Our study aimed to determine subsequent PtDA use in clinical practice following published randomized controlled trials. Design. A descriptive study using an e-mail-embedded questionnaire survey targeting authors of 133 trials included in Cochrane Reviews of PtDAs (106 authors). We classified PtDA level of use as a) implementation, defined as integrating within care processes; b) dissemination to target users with planned strategies; and c) diffusion, defined as passive, unplanned spread. We conducted content analysis to identify barriers and enablers guided by the Ottawa Model of Research Use. Results. Ninety-eight authors responded (92.5%) on 108 trialed PtDAs. Reported levels of use were implementation (n = 29; 28%), dissemination to target user(s) (n = 9; 9%), and diffusion (n = 7; 7%); 57 (55%) reported no uptake, and 1 had no response (1%). Barriers to use in clinical practice were identified at the level of researchers (e.g., lack of posttrial plan), PtDAs (e.g., outdated, delivery mechanism), clinicians (e.g., disagreed with PtDA use), and practice environment (e.g., infrastructure support; funding). Enablers were online delivery, organizational endorsement (e.g., professional organization, charity, government), and design for and integration into the care process. Limitations. Self-report bias and potential for recall bias. Conclusions. Only 44% of PtDA trial authors indicated some level of subsequent use following their trial. The most commonly reported barriers were lack of funding, outdated PtDAs, and clinician disagreement with PtDA use. To improve subsequent use, researchers should codesign PtDAs with end users to ensure fit with clinical practice and develop an implementation plan. National systems (e.g., platforms, endorsement, funding) can enable use.
Patient decision aids (PtDAs) are effective interventions to support patient involvement in health care decisions, but there is little use in practice. Our study aimed to determine subsequent PtDA use in clinical practice following published randomized controlled trials. A descriptive study using an e-mail-embedded questionnaire survey targeting authors of 133 trials included in Cochrane Reviews of PtDAs (106 authors). We classified PtDA level of use as a) implementation, defined as integrating within care processes; b) dissemination to target users with planned strategies; and c) diffusion, defined as passive, unplanned spread. We conducted content analysis to identify barriers and enablers guided by the Ottawa Model of Research Use. Ninety-eight authors responded (92.5%) on 108 trialed PtDAs. Reported levels of use were implementation ( = 29; 28%), dissemination to target user(s) ( = 9; 9%), and diffusion ( = 7; 7%); 57 (55%) reported no uptake, and 1 had no response (1%). Barriers to use in clinical practice were identified at the level of researchers (e.g., lack of posttrial plan), PtDAs (e.g., outdated, delivery mechanism), clinicians (e.g., disagreed with PtDA use), and practice environment (e.g., infrastructure support; funding). Enablers were online delivery, organizational endorsement (e.g., professional organization, charity, government), and design for and integration into the care process. Self-report bias and potential for recall bias. Only 44% of PtDA trial authors indicated some level of subsequent use following their trial. The most commonly reported barriers were lack of funding, outdated PtDAs, and clinician disagreement with PtDA use. To improve subsequent use, researchers should codesign PtDAs with end users to ensure fit with clinical practice and develop an implementation plan. National systems (e.g., platforms, endorsement, funding) can enable use.
Author Suwalska, Victoria
Presseau, Justin
Thomson, Richard
Stacey, Dawn
Boland, Laura
Lewis, Krystina B
Author_xml – sequence: 1
  givenname: Dawn
  orcidid: 0000-0002-2681-741X
  surname: Stacey
  fullname: Stacey, Dawn
  organization: University of Ottawa, Ottawa, ON, Canada
– sequence: 2
  givenname: Victoria
  surname: Suwalska
  fullname: Suwalska, Victoria
  organization: University of Ottawa, Ottawa, ON, Canada
– sequence: 3
  givenname: Laura
  orcidid: 0000-0001-8680-9844
  surname: Boland
  fullname: Boland, Laura
  organization: University of Ottawa, Ottawa, ON, Canada
– sequence: 4
  givenname: Krystina B
  orcidid: 0000-0001-6761-7548
  surname: Lewis
  fullname: Lewis, Krystina B
  organization: University of Ottawa, Ottawa, ON, Canada
– sequence: 5
  givenname: Justin
  surname: Presseau
  fullname: Presseau, Justin
  organization: University of Ottawa, Ottawa, ON, Canada
– sequence: 6
  givenname: Richard
  surname: Thomson
  fullname: Thomson, Richard
  organization: Institute of Health and Society, Newcastle University, Newcastle upon Tyne, Tyne and Wear, UK
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31423911$$D View this record in MEDLINE/PubMed
BookMark eNpNUEtLAzEYDFKxD717khy9rCbZR5KTLLU-oGDRFnor2c0XG9kmNdkt9N-7YAVPMwMzwzBjNHDeAULXlNxRyvk9YZxJIddUikJQmZ6hEc1zlvRiPfjHh2gc4xchNJMiu0DDlGYslZSO0LYMgBeqteBa_Ai1jdY7XFod8SqCxtbhaWOdrVWDF0HVra0BK9NCwO_20wffRTw7qKbrK7x7wCX-6MIBjtgbvAy2T5Vdu_UhXqJzo5oIVyecoNXTbDl9SeZvz6_Tcp7UacrbROSVYJUmIAjRolJGaiOlyUyVmkKYTBQGFBMV54RyojnhhdRCS0nyQhGRsgm6_e3dB__dQWw3OxtraBrloB-7YYznMutPYb315mTtqh3ozT7YnQrHzd877AeXIWhm
CitedBy_id crossref_primary_10_1016_j_cct_2022_106940
crossref_primary_10_1186_s12888_020_02845_0
crossref_primary_10_1016_j_pecinn_2024_100269
crossref_primary_10_1016_j_pecinn_2025_100425
crossref_primary_10_1186_s12911_021_01468_z
crossref_primary_10_1111_jgs_16371
crossref_primary_10_1186_s12882_020_01956_w
crossref_primary_10_1038_s41572_025_00637_y
crossref_primary_10_1186_s12911_023_02186_4
crossref_primary_10_1016_j_rcsop_2021_100039
crossref_primary_10_1016_j_pecinn_2024_100300
crossref_primary_10_1186_s12875_023_02179_2
crossref_primary_10_1016_j_rmed_2021_106568
crossref_primary_10_1186_s12911_020_01251_6
crossref_primary_10_1007_s11606_024_08656_3
crossref_primary_10_3390_genes16040423
crossref_primary_10_1186_s12905_024_03172_2
crossref_primary_10_1016_j_pec_2021_10_026
crossref_primary_10_1080_02687038_2022_2039588
crossref_primary_10_1186_s12911_025_03044_1
crossref_primary_10_1016_j_euo_2024_09_003
crossref_primary_10_1371_journal_pone_0300944
crossref_primary_10_1016_j_pec_2023_107652
crossref_primary_10_1177_0272989X20979693
crossref_primary_10_1186_s12911_025_03084_7
crossref_primary_10_1016_j_jpurol_2022_09_015
crossref_primary_10_1016_j_pec_2022_11_003
crossref_primary_10_1159_000536296
crossref_primary_10_1177_0272989X20978208
crossref_primary_10_1111_nuf_12840
crossref_primary_10_2196_57611
crossref_primary_10_1002_cncr_32959
crossref_primary_10_1016_j_jclinepi_2024_111509
crossref_primary_10_1016_j_jadohealth_2022_10_022
crossref_primary_10_9778_cmajo_20220224
crossref_primary_10_2196_69756
crossref_primary_10_1016_j_pec_2024_108418
crossref_primary_10_1007_s11606_023_08597_3
crossref_primary_10_1186_s12911_023_02259_4
crossref_primary_10_1002_jhm_13475
crossref_primary_10_1016_j_pec_2024_108484
crossref_primary_10_1108_ADD_10_2022_0028
crossref_primary_10_1007_s00198_020_05479_w
crossref_primary_10_1186_s12911_022_02056_5
crossref_primary_10_1371_journal_pone_0259844
crossref_primary_10_3389_fonc_2022_896939
crossref_primary_10_1108_JSM_11_2023_0408
crossref_primary_10_1007_s00415_025_12972_x
crossref_primary_10_1136_bmjopen_2020_037575
crossref_primary_10_1177_0272989X231205858
crossref_primary_10_1016_j_pec_2023_108096
crossref_primary_10_1002_14651858_CD001431_pub6
crossref_primary_10_1093_eurjcn_zvad138
crossref_primary_10_3390_cancers16071390
crossref_primary_10_1016_j_jclinepi_2025_111708
crossref_primary_10_1093_ejendo_lvae050
crossref_primary_10_1001_jamainternmed_2020_0440
crossref_primary_10_1186_s12911_022_01777_x
crossref_primary_10_1177_0272989X251368866
crossref_primary_10_1016_j_fjurol_2025_102868
crossref_primary_10_1177_0272989X211014163
crossref_primary_10_1093_jamiaopen_ooae079
crossref_primary_10_1136_bmjopen_2021_057293
crossref_primary_10_1186_s40900_022_00354_w
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1177/0272989X19868193
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1552-681X
ExternalDocumentID 31423911
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: CIHR
GroupedDBID ---
-TM
.2G
.2J
.2N
.55
.GJ
01A
0R~
123
18M
1~K
29M
31S
31U
31X
31Y
31Z
39C
4.4
53G
54M
5RE
5VS
AABMB
AABOD
AACKU
AACMV
AACTG
AADTT
AADUE
AAEWN
AAGGD
AAJIQ
AAJOX
AAJPV
AAMGE
AANEX
AANSI
AAPEO
AAQDB
AAQQT
AAQXH
AAQXI
AARDL
AARIX
AATAA
AATBZ
AAWTL
AAYTG
ABAWP
ABCCA
ABCJG
ABDWY
ABEIX
ABFWQ
ABHKI
ABHQH
ABIVO
ABJIS
ABJNI
ABKRH
ABLUO
ABPGX
ABPNF
ABQKF
ABQXT
ABRHV
ABUJY
ABVFX
ABVVC
ABYTW
ACARO
ACDSZ
ACDXX
ACFEJ
ACFMA
ACGBL
ACGFO
ACGFS
ACGOD
ACGZU
ACJER
ACLHI
ACLZU
ACMJI
ACOFE
ACOXC
ACROE
ACRPL
ACSBE
ACSIQ
ACTQU
ACUAV
ACUIR
ACXKE
ACXMB
ADBBV
ADEIA
ADNMO
ADNON
ADRRZ
ADTBJ
ADUKL
ADVBO
ADYCS
AECGH
AECVZ
AEDTQ
AENEX
AEPTA
AEQLS
AERKM
AESZF
AEUHG
AEUIJ
AEWDL
AEWHI
AEXNY
AFEET
AFKBI
AFKRG
AFMOU
AFQAA
AFUIA
AFWMB
AGKLV
AGNHF
AGWFA
AGWNL
AHBZF
AHDMH
AHHFK
AHMBA
AIIQI
AIOMO
AJEFB
AJMMQ
AJUZI
AJXAJ
ALKWR
ALMA_UNASSIGNED_HOLDINGS
AMCVQ
ANDLU
ARTOV
ASPBG
AUTPY
AUVAJ
AVWKF
AWUYY
AYAKG
AZFZN
B3H
B8O
B8R
B8Z
B93
B94
BBRGL
BDDNI
BKIIM
BPACV
BSEHC
BYIEH
C45
CAG
CBRKF
CFDXU
CGR
COF
CORYS
CQQTX
CS3
CUY
CVF
DC-
DC.
DD-
DD0
DE-
DF.
DF0
DO-
DOPDO
DV7
D~Y
EBS
ECM
EIF
EIHBH
EJD
F5P
FEDTE
FHBDP
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
H13
HF~
HVGLF
HZ~
IAO
IEA
IH2
IHR
INH
INR
IVC
J8X
K.F
K.J
M4V
N9A
NPM
O9-
OVD
P.B
P2P
PQQKQ
Q1R
Q7K
Q7L
Q7X
Q82
Q83
RIG
ROL
RWL
RXW
S01
SAUOL
SBI
SCNPE
SDB
SFB
SFC
SFH
SFK
SFT
SGA
SGP
SGR
SGV
SGX
SGZ
SHG
SNB
SPJ
SPP
SPV
SQCSI
STM
TAE
TEORI
TN5
X7M
ZGI
ZONMY
ZPPRI
ZRKOI
ZXP
7X8
AAPII
ABIDT
ADDLC
ADEBD
AJGYC
AJHME
AJVBE
SASJQ
ID FETCH-LOGICAL-c337t-85b82bd0e800d8baf9df99f4fb3f68f486fea28b770170d70769d8d99056a0832
IEDL.DBID 7X8
ISICitedReferencesCount 73
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000483236600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1552-681X
IngestDate Sun Sep 28 07:12:55 EDT 2025
Wed Feb 19 02:31:02 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords dissemination
health care
implementation science
patient decision aid
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c337t-85b82bd0e800d8baf9df99f4fb3f68f486fea28b770170d70769d8d99056a0832
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-6761-7548
0000-0002-2681-741X
0000-0001-8680-9844
PMID 31423911
PQID 2275946812
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2275946812
pubmed_primary_31423911
PublicationCentury 2000
PublicationDate 2019-10-00
20191001
PublicationDateYYYYMMDD 2019-10-01
PublicationDate_xml – month: 10
  year: 2019
  text: 2019-10-00
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Medical decision making
PublicationTitleAlternate Med Decis Making
PublicationYear 2019
SSID ssj0014984
Score 2.5231705
Snippet Patient decision aids (PtDAs) are effective interventions to support patient involvement in health care decisions, but there is little use in practice. Our...
Background. Patient decision aids (PtDAs) are effective interventions to support patient involvement in health care decisions, but there is little use in...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 805
SubjectTerms Decision Support Techniques
General Practice - statistics & numerical data
Humans
Information Dissemination
Patient Education as Topic - economics
Patient Education as Topic - methods
Patient Education as Topic - statistics & numerical data
Patient Participation
Randomized Controlled Trials as Topic
Title Are Patient Decision Aids Used in Clinical Practice after Rigorous Evaluation? A Survey of Trial Authors
URI https://www.ncbi.nlm.nih.gov/pubmed/31423911
https://www.proquest.com/docview/2275946812
Volume 39
WOSCitedRecordID wos000483236600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwGA3qRHzxfpk3PsHXsN6TPo2iDh_cKLpB30bTJFqQdrbbwH9v0mbuSRB86UsJbZOvyfm-k5yD0F3gWJxkKjvhluDYsz0fU4-5mHiBk3HXElQ2riXPZDSiSRLGpuBWm22Vqzmxmah5mekaec9xiB96Wi2rP_vE2jVKs6vGQmMTdVwFZXRUk2TNInhh4zisVcawapmsacqeysa09niicm51R9POvwHMZqEZ7P_3FQ_QnoGYELUxcYg2RHGEdoaGRD9G71ElIG71VOHBeOxAlPMaJrXgkBdg1EI_IDaHqKDxEoeX_K2sykUNjz8i4X2I4HVRLcUXlBLGOp5B193Kqj5Bk8Hj-P4JG8MFnLkumWPqM-owNWoKRXLKUhlyGYbSk8yVAZUeDaRIHcoI0ao7nFgkCDnlakHzg1RhOecUbRVlIc4REG4xh5FU-lRlOFZKNT-o4aTKYGzmB110u-rDqQpozVKkhVAfMF33YhedtQMxnbXKG1PX1nqFtn3xh9aXaFc_sN14d4U6Uv3O4hptZ8t5Xlc3TaSo6ygefgOuC8Yj
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Are+Patient+Decision+Aids+Used+in+Clinical+Practice+after+Rigorous+Evaluation%3F+A+Survey+of+Trial+Authors&rft.jtitle=Medical+decision+making&rft.au=Stacey%2C+Dawn&rft.au=Suwalska%2C+Victoria&rft.au=Boland%2C+Laura&rft.au=Lewis%2C+Krystina+B&rft.date=2019-10-01&rft.issn=1552-681X&rft.eissn=1552-681X&rft.volume=39&rft.issue=7&rft.spage=805&rft_id=info:doi/10.1177%2F0272989X19868193&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1552-681X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1552-681X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1552-681X&client=summon